Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arqule Inc (NQ: ARQL )

20.00 USD UNCHANGED
Last Price Updated: 5:01 PM EST, Jan 15, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Arqule Inc

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
These 2 Stocks Could Be 2020's Best Profit Opportunities
How do we find the top stock of 2020? The best performers in 2019 offer some clues. 
Tags NVAX Market News AAPL
From Motley Fool
The 10 Best-Performing Micro-Cap Stocks of 2019
In 2019 the S&P 500 Index rose an astounding 29%. Much of that gain is the result of a horrible end to 2018 that saw stocks bottom the day before Christmas. Here were the 10 best-performing micro-cap... 
Tags Pharma/Biotech
From Blogs - TalkMarkets
Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer
It's a good bet the buyer thinks the stock is going to go up. 
Tags MRK DLTR Market News
From Motley Fool
These Were the 10 Best Stocks of 2019
Seven biotechs led the way. 
Tags DRRX EVER RCEL
From Motley Fool
Why Biotech Stock ArQule Soared 108% in December
This cancer-drug developer received a buyout offer from a big pharmaceutical company. 
Tags MRK Market News ARQL
From Motley Fool
Here are the best-performing Nasdaq stocks of 2019
AMD, Lam Research and KLA top the list. 
Tags NMRK ACGL LULU
From MarketWatch
A Perspective On Biopharma's Record M&A Run In 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ... 
Tags BMRN ALNY SRPT
From Benzinga
These Were the 10 Best Healthcare Stocks of 2019
Helping people stricken with illness can be richly rewarding in more ways than one. 
Tags ARWR ARQL GH
From Motley Fool
Why Aptose Biosciences Shares Are Jumping Today
Investors excited about the biotech's prospects are taking the opportunity to buy on the dip following the announcement of a new stock offering. 
Tags ARQL Market News APTO
From Motley Fool
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
Biotech stocks were seen consolidating last week after advancing in the previous week. The iShares NASDAQ Biotechnology Index (NASDAQ: ... 
Tags Trading Ideas General Previews
From Benzinga
Better Buy: Eli Lilly vs. Merck
Which of these two pharmaceutical giants is poised to produce healthier returns? 
Tags LLY Market News NVO
From Motley Fool
Notable Thursday Option Activity: FOSL, ARQL, ATNX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fossil Group Inc (FOSL), where a total volume of 7,870 contracts has been traded... 
Tags Stocks
From Market News Video
There’s more upside for biotech even after 24% gains in two months
Seven biotech stocks to consider buying. 
Tags NVS ARQL SAGE
From MarketWatch
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags BHC FLXN KDMN
From Benzinga
Hot Options Report For End Of Day - Wednesday, Dec. 11
Top tickers for end of day: DHR, ARQL, AAPL, F, GILD, FANG, PCG. 
Tags Options
From Blogs - TalkMarkets
Why Merck, Sanofi News Helped This Biotech Rocket 31% Over Two Days
Principia Biopharma stock has rocketed 31% this week amid enthusiasm for its technology, BTK inhibition — highlighted by notable moves from pharmaceutical giants Merck and Sanofi. 
From Investor's Business Daily
Most Active Equity Options For Midday - Wednesday, Dec. 11
Top tickers for midday: AAPL, DHR, TSLA, BAC, BA, MU, FCX, NFLX, AMD, MSFT, BABA, F, PCG, HD, DIS, FANG, ROKU, GME, PTON, ARQL. 
Tags Options
From Blogs - TalkMarkets
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags MDCO RHHBY KIDS
From Benzinga
Why Biotech ETFs Are Surging To New Highs
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive... 
Tags ETFs Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Hot Options Report For End Of Day - Tuesday, Dec. 10
Top tickers for end of day: DHR, AAPL, ARQL, F, LPI, T. 
Tags Options
From Blogs - TalkMarkets
Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting
A handful of sickle cell disease treatments and CAR-T therapies that treat cancer have been approved by the Food and Drug Administration in recent years, but a new crop of investigational therapies... 
Tags General JNJ ARQL
From MarketWatch
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ... 
Tags NLOK XENE DPMLF
From Benzinga
Most Active Equity Options For Midday - Tuesday, Dec. 10
Top tickers for midday: AAPL, TSLA, DHR, AMD, NFLX, ARQL, BABA, T, FB, AMZN, ROKU, BAC, NVDA, MU, DIS, MSFT, BMY, SFIX, SQ, CGC. 
Tags Options
From Blogs - TalkMarkets
Benzinga's Top Upgrades, Downgrades For December 10, 2019
Upgrades JP Morgan changed the rating for Adecoagro SA (NYSE: AGRO) from Neutral to Overweight. For the third quarter, Adecoagro ... 
Tags Financials KRC CHD
From Benzinga
10 Biggest Price Target Changes For Tuesday
SunTrust Robinson Humphrey raised Hilton Hotels Corporation (NYSE: HLT) price target from $111 to $121. Hilton Hotels shares closed ... 
Tags CSX NKE ARQL
From Benzinga
ArQule Reaches Analyst Target Price
In recent trading, shares of ArQule Inc. (ARQL) have crossed above the average analyst 12-month target price of $13.57, changing hands for $19.70/share.. 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week ... 
Tags ASRT MTP HTGM
From Benzinga
80 Biggest Movers From Yesterday
Gainers Synthorx, Inc. (NASDAQ: THOR) shares jumped 170.5% to close at $67.71 on Monday after the company announced it would be ... 
Tags NERV Trading Ideas CNTG
From Benzinga
Drugmakers have spent a record $342 billion on M&A in 2019
A string of multibillion-dollar pharmaceutical deals announced over the last week call attention to a record-setting year in which drugmakers and biotechs have spent $342 billion snapping up smaller... 
Tags XBIT M&A Health/Care
From MarketWatch
What Happened in the Stock Market Today
Two big deals for cancer drug companies made news today. Merck plans to buy ArQule and Sanofi will pay up to buy Synthorx. 
Tags ARQL SNY Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.